In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more here.

Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

However, GRAPPA asserts that there is grade A evidence for use of infliximab or etanercept in severe enthesitis ... the target of all treatment strategies in psoriatic arthritis.

Fatigue is a common problem for people with psoriatic arthritis. According to the National Psoriasis Foundation, some studies indicate that half of all psoriatic arthritis patients have ...

However, patients have gone on with severe disease before the advent ... patients about their options and in terms of treatment of psoriatic arthritis. If you have any additional questions ...

When children and teens get PsA, the condition is called juvenile PsA.Juvenile PsA is a type of juvenile idiopathic arthritis ...

US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...

Lifestyle changes become critical components of arthritis management. An appropriate diet, low-impact exercise, and ...

Treatment for arthritis is mainly focused on symptom management and slowing the progression of the disease, says Dr Vishal ...

These topical drugs can help provide pain relief for people with arthritis that is in just a few joints, such as a hand, or for people whose pain isn't severe. Nonsteroidal anti-inflammatory drugs ...

Secukinumab is a fully human anti-IL-17A monoclonal antibody that is currently under trial in moderate-to-severe PsA ... target of all treatment strategies in psoriatic arthritis.